Clinical Trials Logo

Executive Dysfunction clinical trials

View clinical trials related to Executive Dysfunction.

Filter by:

NCT ID: NCT00271596 Completed - Huntington Disease Clinical Trials

Citalopram to Enhance Cognition in HD

CIT-HD
Start date: November 2005
Phase: Phase 2
Study type: Interventional

This research plan proposes to conduct a double-blind, placebo-controlled pilot clinical trial in 36 adults with mild Huntington's disease (HD) to address the following research aims: 1. To determine the effect of citalopram compared to placebo in patients with early HD on executive function and other outcome variables including functional measures (health-related quality of life, work productivity, and self-reported attention), motor performance, and psychiatric status, 2. To study the relationship between executive function and functional status in patients with early HD after selective serotonin reuptake inhibitor (SSRI) treatment, and 3. To examine the effect of citalopram treatment on volumetric and metabolic (i.e, N-acetyl-aspartate concentration) measures in the neostriatum among patients with recently diagnosed Huntington's disease.